Increased susceptibility of the aging brain to both chronic stress and incipient dementia-related neuropathology may accelerate cognitive decline. We investigated associations between chronic stress and diagnostic change in 62 individuals (mean age, 78.7 y) participating in an Alzheimer disease research center longitudinal study. The subjects, diagnosed at baseline as cognitively normal (CN) or with mild cognitive impairment (MCI), were followed for an average of 2.5 years. Senior neurologists, blind to detailed measures of stress and cognition, assigned diagnoses annually. Logistic regression analyses assessed the accuracy with which measures of stress (event-based ratings, cortisol levels) predicted the conversion to MCI and dementia. Eleven individuals with MCI at baseline received a dementia diagnosis during followup. Sixteen converted from cognitively normal to MCI. Prolonged, highly stressful experiences were associated with conversion from MCI to dementia. The cortisol awakening response, with age and education, was associated with a diagnostic change to MCI. Cortisol measures were not associated with the progression from MCI to dementia, and there was no association between stressful experiences and the change to MCI. Mechanisms associated with the transition from normal cognition to MCI may differ from those associated with a diagnostic change to dementia. These findings could facilitate the identification of interventional strategies to reduce the risk of decline at different stages of susceptibility.
T he negative effects of stress on health have been acknowledged in the scientific literature for decades. More recently, however, investigators have focused on the effects of stress, particularly chronic stress, on the brain. Life event checklists 1, 2 and levels of the stress hormone cortisol [3] [4] [5] [6] [7] are among the most commonly used measures of chronic stress. Cognitive decline and associated diagnoses are often targeted as proxies for stress-related neuropathologic changes. Stress-related cognitive decline is thought to result from the effects of prolonged elevations of cortisol, a hypothalamic-pituitary-adrenocortical (HPA) axis response to chronic stress. This response targets specific brain regions including the hippocampus, amygdala, and prefrontal cortex. 8 The hippocampus, the region that has received the most attention as a target of HPA axis response, 5, 6, 9 is critical for certain types of memory [10] [11] [12] and is considered to be the initial site of the neuropathology of Alzheimer disease, 13 the most common form of dementia. The relationship between chronic stress and cognitive decline is particularly important for the health of older adults who are more susceptible to HPA axis dysfunction 12, [14] [15] [16] and at a greater risk for developing dementia. 16, 17 Cognitive decline could result from additive effects in which chronic stress increases the vulnerability to other types of neuropathologic insults 18 or vice versa. In contrast, recent animal studies have shown a more direct or possibly causative link between stress and neuropathology associated with dementia, demonstrating that stress is associated with synapse loss, 19 increases in amyloid b-peptide, [20] [21] [22] and tau accumulation and phosphorylation. 21, 22 Regardless of the mechanism, the effects of chronic stress on cognition may depend on the extent of existing neuropathologic changes. Very early cognitive changes in older adults are often relatively circumscribed and cause minimal interference with daily functioning. This level of cognitive decline is usually identified as mild cognitive impairment (MCI) 23 and is sometimes considered a "preclinical" stage of dementia. In a recent longitudinal study, 24 we found that highly stressful events were associated with memory decline in MCI subjects over a 2-year to 3-year period. However, a high level of cortisol (determined by the mean of 5 measures distributed throughout the day) was not associated with a decline in subjects with MCI. These data suggest a differential effect of cortisol level on cognition depending on the extent of neuropathologic change, a finding supported by results from another study measuring both cognitive performance and neuropathologic changes in rats. 25 Numerous studies have identified associations between measures of chronic stress and cognitive decline. Identifying methods to better characterize chronic stress in aging, however, may have a significant impact on the relevance of these associations. Previous studies have measured primarily event-based stress using simple checklists that do not consider context and, therefore, may overlook important details such as threat severity and duration and multiple instances of events. In the current study, we used a comprehensive measure of stressful events and difficulties [life events and difficulties schedule (LEDS)] 26 that considers contextual details, documents multiple occurrences, and uses strategies to improve response reliability.
Previous studies focusing on cortisol levels as a measure of stress have targeted different aspects of the cortisol diurnal cycle. [27] [28] [29] For example, an overall diurnal average, and single measures at specific times of the day, have been used. Another aspect cited frequently is the morning cortisol awakening response (CAR), an index of HPA activity, 27, 30 that in healthy individuals is defined as a sharp rise in cortisol release from the level at morning awakening to the "peak" approximately 30 minutes later. Investigators reported a consistent increase of at least 50% within the first 30 minutes after awakening in over 500 healthy subjects ranging in age from 18 to 71 years, 31 confirming and extending findings concerning a normal cortisol diurnal rhythm from previous studies. 30, 32, 33 Of particular importance for this study are numerous reports of a decline in the CAR percent change in response to prolonged stress. 27, 30, [34] [35] [36] There is evidence that the magnitude of the CAR is independent of the cortisol diurnal mean that takes a range of daytime samples into account, 37 and that significant neuropathology (ie, hippocampal) is associated with the absence of an increase in cortisol in response to awakening 34, 38 and to psychosocial stress. 39 Although the exact function of the CAR is unknown, some investigators note that it may represent an HPA axis response activated endogenously by the act of awakening. 30, 40 Other investigators have characterized the sharp increase of the CAR as a reflection of the recall and anticipation of upcoming demands of the day (ie, prospective memory). 27, 41 We used a measure of the CAR as 1 feature of the diurnal cycle, but addressed the utility of 2 additional aspects, (1) average of the 5 diurnal samples (awakening, 30 min after awakening, 2 PM, 4 PM, bedtime) (diurnal mean) and (2) average of the afternoon and evening (2 PM, 4 PM, bedtime) samples (postpeak mean) to assess their associations with the progression of cognitive decline over individualized follow-up intervals. Finally, accepting the assumption that diagnostic status represents neuropathologic changes, we used the diagnostic status to stage progression. Our goal was to investigate the effects of behavioral measures and biomarkers of chronic stress as they relate to diagnostic change from MCI to dementia and from cognitively normal (CN) to MCI over a mean followup interval of 2.5 years. That is, we examined whether the effects of specific longitudinal measures of chronic stress improve the prediction of change in diagnosis at 2 discrete levels of disease severity.
METHODS

Participants
Volunteers above the age of 65 and living independently were recruited from the UCSD Shiley-Marcos Alzheimer's Disease Research Center and Memory Screening Clinic. Sixty-two participants with at least 3 visits over follow-up were included. Individuals were excluded if found to have dementia, a significant medical disorder (eg, insulin-dependent diabetes, chronic inflammation), or a prominent psychiatric condition (eg, depression 42 ; post traumatic stress disorder 43 ), or if using corticosteroid medications that could affect daily cortisol levels. Topical corticosteroids were permitted, as were steroidal inhalants if discontinued the day before and the day of sampling. Nonsteroidal anti-inflammatory (19% of subjects), hormonal (14%), narcotic (10%), anxiolytic (17%), and thyroid (29%) medications were allowed if the participant was on a stable dose for at least 6 months before baseline. We used statistical analyses to determine whether any of these medications had a significant effect on the cortisol level.
Each participant was functioning independently in daily activities according to a knowledgeable informant, the majority of whom were spouses. Neuropsychological testing included measures of global cognition (Dementia Rating Scale 44 ), memory (eg, California verbal learning test 45 ), attention (eg, digit span 46 ), executive functions (eg, trail making, 47 Wisconsin card sort test 48 ), visuospatial ability (eg, block design 49 ), and language (eg, Boston naming test, 50 verbal fluency 51 ). There were 29 CN and 33 MCI subjects at baseline. MCI subjects were classified as amnestic and single domain (n = 21), nonamnestic and single domain (n = 9: 8 executive function, 1 visuospatial), and multiple-domain, which included memory impairment (n = 3). No participant met the criteria for dementia using the Diagnostic and Statistical Manual of Mental Disorders, 4th edition or NINCDS-ADRDA criteria. 52 Subjects attended an average of 4.9 visits (SD = 1.9); the mean follow-up was 2.5 years (SD = 1.1).
General Procedure
After reading the study description, the subject and informant signed separate written informed consents approved by the UCSD Human Research Protections Program. The informant usually joined the participant for the LEDS interview, but if unable, consented to provide information by phone. Measures of stress were obtained at baseline and thereafter at 6-month intervals; neurological, neuropsychological, and medical evaluations were completed annually.
Diagnostic Procedure
Diagnoses were made by senior neurologists on the basis of functional, neurological, medical, and limited neuropsychological (yes/no to questions of memory deficits and Z2 areas of impairment) information. A diagnosis of MCI-single domain was based on the Petersen criteria, requiring impairment in 1 area of cognitive functioning and essentially intact functional capacity. 23 A diagnosis of MCI-multiple domains was assigned if the subject had mild impairment in more than 1 cognitive domain, but did not have sufficiently severe cognitive or functional impairment to meet the criteria for dementia. All study personnel were blind to stress measures and details of the neuropsychological battery.
Assessment of Chronic Stress
The LEDS 26 is a semistructured interview in which the participant reviewed a list of events and difficulties divided into categories (eg, health, finances) to identify potentially stressful experiences during the 12 months before baseline and 6 months before each follow-up visit. The LEDS is based on the premise that experiences that cause considerable long-term threat are likely to be associated with medical and psychiatric disorders. It emphasizes the chronicity of ongoing difficulties ( >2-week duration), and discrete events serious enough to cause long-term threat. Following methods described previously, 53 the interviewer probes for information about the event context (eg, duration) and constructs a detailed description used by a trained professional to determine the degree of threat Alzheimer Dis Assoc Disord Volume 26, Number 3, July-September 2012
Chronic Stress and Diagnostic Change (high vs. low) for each event and difficulty. Only those experiences determined to be severely threatening events or marked difficulties over the "long term" receive a high stress rating.
Cortisol Measures
Sampling cortisol in saliva is a reliable, noninvasive method to assess circulating cortisol levels 54, 55 and HPA axis function. Cortisol has been shown to be highly stable under a broad range of handling and temperature storage conditions. [56] [57] [58] For each visit, participants followed detailed instructions at their homes to produce 5 saliva samples within 1 day using "salivettes" (Sarstedt Inc., Newton, NC). Samples were produced at awakening, 30 minutes later, 2 PM, 4 PM, and bedtime, and refrigerated until delivered in person to the study personnel. Samples then were frozen (À201C) until delivered to the General Clinical Research Center Core Laboratory for analysis. In this study and prior studies from the Core Laboratory, no sample degradation because of study design, methodology, or sample handling has been observed. Measures of cortisol response over time included the average of all 5 diurnal samples (diurnal mean), the average of the 2 PM, 4 PM, and bedtime samples (postpeak mean), and the CAR. The CAR was calculated by dividing the difference between the awakening and 30-minute postawakening samples by the awakening measure.
Cortisol EIA kits (Cat# 1-3002) were purchased from Salimetrics LLC (State College, PA). Samples, standards, controls, and cortisol-horseradish peroxidase conjugate were added to a microplate coated with the mAb to cortisol and incubated at room temperature for 1 hour; unbound components were washed, and the bound cortisol-horseradish peroxidase was measured using tetramethylbenzidine substrate. The color was read on a Spectramax M-5 (Molecular Devices, Sunnyvale, CA) multifunctional plate reader equipped with SoftmaxPro v5.4 (SMP 5.4), and a 5-parameter sigmoid minus curve fit determined unknown concentrations. The intra-assay and inter-assay precisions were 0.01 to 2.5% and 3.0 to 8.0%, respectively. The coefficient of variation of duplicates varied from 0.01 to 2.5%.
Statistical Analyses
We investigated 2 types of diagnostic changes: (1) from a baseline diagnosis of MCI to a diagnosis of dementia, and (2) from a baseline diagnosis of CN to a diagnosis of MCI. P-values were considered significant if <0.05. Three subjects with a baseline diagnosis of MCI and a subsequent persisting diagnosis of CN were considered CN throughout.
To assess whether there was an effect of medications on the cortisol level, we used t tests to compare cortisol mean values for all subjects divided by whether they were on or off each medication (ie, nonsteroidal anti-inflammatory, hormonal, narcotic, anxiolytic, thyroid). These comparisons yielded no significant differences. In addition, t tests yielded no significant differences in the means or the variances of the CAR when all subjects were divided by sex or by median split at the time of awakening or age. 27 Stress measures were longitudinal and included the total number of high stress LEDS ratings and the cortisol diurnal mean, postpeak mean, and the CAR averaged for each subject over the individualized length of follow-up. Six variables including the total number of high stress ratings, 1 measure of cortisol, variables considered risk factors for dementia [age, education, presence or absence of at least 1 apolipoprotein-E e4 allele (APOE-e4)] and the sex were included in each of the logistic regression analyses. All variables entered were continuous except the sex and the APOE-e4 status.
Because predictive accuracy is based on the fitted model in the logistic regression and is likely to overestimate the ability of the model to predict diagnostic change, we used a 10-fold cross-validation to adjust for "out-ofsample" differences and to estimate the sensitivity and specificity of the fitted model.
RESULTS
Eleven of the 33 participants with a diagnosis of MCI at baseline (33.3%) received a diagnosis of dementia during the follow-up interval; 22 retained a diagnosis of MCI. Four of the 11 who changed received a dementia diagnosis after 1 year, 2 after 2 years, 4 after 3 years, and 1 after 4 years. Sixteen of the 29 subjects who were CN at baseline received a diagnosis of MCI during the follow-up interval. The remaining 13 CN subjects remained cognitively intact. Ten of the 16 who changed received an MCI diagnosis after 1 year, 4 after 2 years, and 2 after 3 years. There were 3 CN subjects who progressed to MCI and subsequently to dementia. These subjects were included only in the analyses addressing the change from CN to MCI, and only their visits before the conversion to dementia were considered. Table 1 shows means and SDs for baseline age, education, baseline Dementia Rating Scale score, and longitudinal stress measures for all subjects. The percentages of subjects who were women, diagnosed with MCI at baseline, and possessed at least 1 APOE-e4 allele were also shown. Table 2 shows the same measures for subjects divided by the type of diagnostic change (ie, CN to MCI and MCI to dementia).
Logistic Regression Analyses
Each logistic regression model to predict diagnostic change included 6 variables: age, education, sex, APOE-e4 allele status, and longitudinal stress measures (ie, the total number of LEDS high ratings and one of the 3 cortisol measures). The overall w 2 values for all models predicting a diagnostic change from MCI to dementia were significant (Table 3) , as was 1 predictor variable, the total number of high stress LEDS ratings. On the basis of a 10-fold cross-validation, the sensitivity was 53.8% and the specificity 91.6%.
The same 6 predictor variables were entered to assess the ability to classify individuals progressing from a diagnosis of CN to MCI. The overall w 2 values for all 3 models were significant (Table 4 ). Age and education were retained in the regression equation in all 3 models regardless of the cortisol measure included. However, only 1 measure of cortisol, the CAR, was retained along with age and education. For this model, the sensitivity was 79.9 and the specificity 69.7, on the basis of the 10-fold cross-validation.
DISCUSSION
Previous studies have provided evidence of a link between chronic stress and dementia-related diagnostic change in older adults. 59, 60 We addressed this association using a comprehensive, longitudinal assessment of chronic stress based on LEDS and 3 cortisol measures derived from samples extending across the diurnal cycle. We found that a diagnostic change to dementia was associated with a relatively higher number of highly stressful life events and difficulties but not with cortisol measures. A change from CN to MCI, however, was associated with a relatively lower level of 1 cortisol measure, the CAR, but not with other cortisol measures or the number of stressful life experiences.
The results addressing a diagnostic change from MCI to dementia are consistent with those from a previous study 24 in which memory decline in MCI subjects was associated with stressful life experiences. This suggests that prolonged stress affects aspects of the HPA axis other than or in addition to changes in the overall cortisol release. The cortisol response may impact brain regions to a lesser degree as neuropathologic compromise progresses to later stages of MCI and ultimately to dementia. It is possible that once the hippocampus reaches a certain level of compromise such as that identified in MCI, 61 there is a shift in the regulatory mechanism from the hippocampus to other 62 and dementia.
Although the current study did not show a relationship between the cortisol diurnal mean and the conversion to MCI or dementia, we did find that a widely studied aspect of the cortisol diurnal cycle, the CAR, 8, 27, [30] [31] [32] [33] [34] [35] [36] [37] [38] 40, 41 was useful in predicting a diagnostic change in the early (CN to MCI) stages of cognitive decline. This cortisol response to stress may signal damage to neurons and their connections in the early stages of neuropathologic changes, a finding consistent with the notion that mechanisms associated with the transition to MCI may differ from those associated with the transition to dementia. Additional evidence for this differential effect is supplied by a study 25 showing that prolonged glucocorticoid treatment in rats prescreened for cognitive impairment had a negative effect on subsequent learning and memory in the "nonimpaired" group but not in the "impaired" group. The authors noted a higher percentage of increase in cell damage in the hippocampus (CA1 region) in "nonimpaired" subjects relative to those "impaired." Findings from a recent study addressing memory performance in healthy, human subjects 63 also suggest that the association between cortisol and memory in aging depends on the presence or the absence of cognitive impairment assumed to reflect neuropathologic changes; in the MCI group, high cortisol levels were associated with poorer learning and immediate memory, and in the healthy elderly, high cortisol levels were associated with better performance on delayed memory. Although these findings seem inconsistent with those of other studies drawing the same conclusion, it is difficult to compare the results because of significant methodological differences. Unlike our study, the study by Souza-Talarico et al 63 included slightly younger, less educated subjects, measured memory performance at 1 time point, assessed visual memory (ie, 10-line drawings) only, and obtained 1 saliva sample for the cortisol measure at a variable time point within 2 hours of awakening. Additional longitudinal studies are necessary to understand how cortisol dynamics affect cognition as older individuals progress through stages of increasing impairment.
A normal CAR has been defined as a sharp increase in cortisol release from morning awakening to the "peak" approximately 30 minutes later. 31 Findings from the current study suggest that the CAR is involved in, or reflects the mechanisms involved in, the transition from intact cognitive functioning to MCI. There is evidence that the magnitude of the CAR is independent of the average of cortisol measures from samples taken across the day, and changes in the CAR have been associated with HPA axis dysregulation, hippocampal damage, and even developmental/personality factors (eg, self-esteem). 8 One interpretation of its function 27 is that the CAR increases in anticipation of daily activities at awakening; the sharp increase in cortisol may decrease when impaired prospective recall precludes this anticipatory response. Other investigators 64 have proposed a process that releases the sensitivity of the adrenal response (eg, cortisol) to pituitary activity from a preawakening reduction, and then increases the sensitivity postawakening in response to light. The latter is mediated by an extrapituitary pathway to the adrenal through the suprachiasmatic nucleus, a central pacemaker for circadian rhythms. Although these ideas do not provide an obvious explanation for the association between the CAR and the transition to MCI, they provide directions for additional studies to address relationships among cortisol circadian rhythm, HPA axis regulation, involvement of specific brain regions, and cognitive decline in aging.
In order to apply the study findings to clinical practice, they must be replicated in larger, independent subject samples. Cautious speculation, however, could lead to clinically useful ideas. Because models addressing progression to dementia showed good specificity but relatively lower sensitivity, we might predict that individuals with existing cognitive impairment (ie, MCI) but relatively low chronic stress based on events and difficulties are not likely to progress rapidly to dementia. We, however, would expect less accurate predictions for those experiencing significant chronic stress. For the model addressing progression from CN to MCI, both sensitivity and specificity were only moderately elevated when the CAR was entered as a continuous variable. However, of the 8 subjects with a CN diagnosis at baseline and a change in the CAR>50% over follow-up, only 2 (25%) progressed to MCI; of the 21 subjects with a CN diagnosis at baseline and a change in the CAR<50% over follow-up, 14 (67%) progressed to MCI. The CAR cut point of 50% change reported in a large sample by Wust et al 31 could prove useful if presented with other information (eg, age, education) in a clinical setting.
One limitation of this study is the relatively small sample size that may have precluded the detection of effects that would have been identified with a larger sample size. A second limitation, given our specific aims and methodology, is the absence of information concerning the effects of additional factors that could influence how stress affects diagnostic change (eg, coping strategies, lifetime stressors). Third, the percentage of subjects who progressed from CN to MCI was higher than expected. The volunteer status of subjects may have introduced selection bias by attracting subjects with concerns about memory. A significant proportion of the CN subjects had memory complaints at enrollment; it is possible that some of the complaints were associated with deficits not detected on neuropsychological testing. 65, 66 Finally, survival analysis would have been a likely statistical candidate for addressing diagnostic change over time. Subjects received diagnoses annually, and we only know that a diagnostic change occurred at some point in the 12 months between visits; therefore, these data are interval censored. Because a standard survival analysis (eg, Cox proportional hazards regression) was developed for dealing with right-censored data (ie, exact survival time becomes incomplete at the end or right side of follow-up), we concluded that fitting such a model would produce biased and potentially misleading results.
Despite the limitations, findings from this study suggest an important link between specific measures of stress and diagnostic change that, with appropriate replication in larger, randomized samples, could improve our ability to estimate the level of risk for cognitive decline in older adults. Disruption of this link using low-cost, low-risk behavioral interventions designed to modify responses to stress could significantly enhance the efforts to prevent or slow disease progression in individuals at a heightened risk of dementia.
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